Urological cancer: CHAARTED/GETUG 12-docetaxel in non-castrate prostate cancers Journal Article


Authors: Teo, M. Y.; Scher, H. I.
Article Title: Urological cancer: CHAARTED/GETUG 12-docetaxel in non-castrate prostate cancers
Keywords: overall survival; prednisone; disease course; cancer combination chemotherapy; drug efficacy; treatment duration; multiple cycle treatment; cancer mortality; high risk patient; docetaxel; prostate cancer; mitoxantrone; short survey; zoledronic acid; castration resistant prostate cancer; recurrence free survival; randomized controlled trial (topic); phase 3 clinical trial (topic); disease activity; estramustine; human; priority journal; metastatic castration resistant prostate cancer; non castrate prostate cancer
Journal Title: Nature Reviews Clinical Oncology
Volume: 12
Issue: 12
ISSN: 1759-4774
Publisher: Nature Publishing Group  
Date Published: 2015-12-01
Start Page: 687
End Page: 688
Language: English
DOI: 10.1038/nrclinonc.2015.192
PROVIDER: scopus
PUBMED: 26552950
DOI/URL:
Notes: Short Survey -- Export Date: 7 January 2016 -- 687 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Howard Scher
    1130 Scher
  2. Min Yuen   Teo
    104 Teo
Related MSK Work